Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Species
- (2)
- (2)
- (6)
- (6)
- (6)
- (6)
- (2)
- (11)
- (1,874)
- (106)
- (1)
- (1)
- (4)
- (51)
- (1)
- (8)
- (2)
- (15)
- (1)
- (458)
- (8)
- (1)
- (1)
- (28,493)
- (1)
- (8)
- (3)
- (15)
- (1)
- (3)
- (13)
- (1)
- (7)
- (1)
- (3)
- (2)
- (3)
- (4)
- (3)
- (2)
- (5)
- (3)
- (3)
- (4)
- (4)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (30,169)
- (202)
- (27)
- (19)
- (17)
- (8)
- (4)
- (1)
- (3)
- (2)
- (6)
- (218)
- (4)
- (2)
- (1,065)
- (18)
- (2)
- (1)
- (2)
- (14)
- (1)
- (53)
- (2)
- (2)
- (2)
- (1)
- (42)
- (13)
- (46)
- (31)
- (2)
- (62)
- (4)
- (165)
- (178)
- (13)
- (12)
- (3)
- (8)
- (4)
- (156)
- (4)
- (3)
- (3)
- (2)
- (2)
- (2)
- (14)
- (30,024)
- (4)
- (4,516)
- (2)
- (4)
For Use With (Application)
- (1)
- (2,853)
- (1)
- (28,533)
- (30)
- (65)
- (349)
- (5,638)
- (24)
- (8)
- (2)
- (8)
- (21,464)
- (2)
- (1)
- (7)
- (56)
- (2)
- (1)
- (2)
- (2)
- (3)
- (1)
- (5)
- (248)
- (23,446)
- (1)
- (16)
- (1)
- (28)
- (4)
- (50,669)
- (407)
- (2)
- (4)
- (32)
- (716)
- (4)
- (3)
- (199)
- (1)
- (1)
- (126)
- (4,358)
- (1,567)
- (3)
- (62)
- (7)
- (3)
- (4)
- (1)
- (19,636)
- (17)
- (31)
- (19)
- (1)
- (3)
- (179)
- (16)
- (3)
- (116)
- (150)
- (97)
- (2)
- (12)
- (4)
- (1)
- (1,607)
- (2)
- (4)
- (1)
- (18)
- (17)
- (11)
- (2)
- (1)
- (6)
- (500)
- (1)
- (4,211)
- (4)
- (1)
- (8)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (47,854)
- (197)
- (15)
- (2)
- (196)
- (62)
- (4)
- (6)
- (22)
- (1)
- (6)
- (196)
- (1)
- (8,258)
- (4)
- (4)
- (13)
- (2)
- (4)
- (11)
- (5)
- (8)
- (1)
- (50,479)
- (238)
Recombinant
- (10)
- (67,858)
Form
- (3)
- (19)
- (49,941)
- (7,386)
- (3,604)
- (136)
- (13)
- (3,409)
Conjugate
- (2)
- (1)
- (66)
- (1)
- (4)
- (2)
- (11)
- (64)
- (1)
- (4)
- (4)
- (1)
- (409)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (4)
- (2)
- (100)
- (12)
- (2)
- (3)
- (2)
- (2)
- (1)
- (14)
- (677)
- (1)
- (2)
- (3)
- (46)
- (42,478)
- (2)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Keyword Search:
Clear search
1
–
15
of
78,791
results
1
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | PDGF-BB |
| Molecular Weight (g/mol) | 24.3 kDa |
| Gene Symbol | PDGFB |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | SLGSLTIAEP AMIAECKTRT EVFEISRRLI DRTNANFLVW PPCVEVQRCS GCCNNRNVQC RPTQVQLRPV QVRKIEIVRK KPIFKKATVT LEDHLACKCE TVAAARPVT |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human PDGF-BB |
| Accession Number | P01127 |
| Regulatory Status | RUO |
| Gene Alias | becaplermin; c-sis; FLJ12858; H-PDGF-BB; IBGC5; PDGF; pdgf protein; PDGF subunit B; PDGF, B chain; PDGF2; PDGF-2; PDGFB; PDGF-B; platelet derived growth factor subunit B; platelet derived growth factor, B polypeptide; platelet-derived growth factor 2; platelet-derived growth factor B; platelet-derived growth factor B chain; platelet-derived growth factor beta; platelet-derived growth factor beta polypeptide; platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog); platelet-derived growth factor subunit B; platelet-derived growth factor, beta polypeptide (oncogene SIS); Platelet-derived growth factor, same as Sis (Simian sarcoma viral oncogene homologue, c-sis); proto-oncogene c-Sis; Sis; SSV |
| Biological Activity | Determined by the dose-dependent stimulation of the proliferation of Balb/c 3T3 cells.The expected ED50 for this effect is 1.0-3.0 ng/ml |
| Gene ID (Entrez) | 5155 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
2
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | M-CSF |
| Molecular Weight (g/mol) | 36.8 kDa |
| Gene Symbol | Csf1 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MEEVSEYCSH MIGSGHLQSL QRLIDSQMET SCQITFEFVD QEQLKDPVCY LKKAFLLVQD IMEDTMRFRD NTPNAIAIVQ LQELSLRLKS CFTKDYEEHD KACVRTFYET PLQLLEKVKN VFNETKNLLD KDWNIFSKNC NNSFAECSSQ GHERQSEGS |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human M-CSF |
| Accession Number | P09603 |
| Regulatory Status | RUO |
| Gene Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
| Biological Activity | The ED50 was determined by the dose-dependent stimulation of the proliferation of murine M-NSF-60 cells ≤ 1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 1435 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
3
| Accession Number | P02649 |
|---|---|
| Regulatory Status | RUO |
| Purity or Quality Grade | ≥ 90% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene ID (Entrez) | 348 |
| Formulation | protein with no preservative |
| Gene Symbol | APOE |
| Sequence | MKVEQAVETE PEPELRQQTE WQSGQRWELA LGRFWDYLRW VQTLSEQVQE ELLSSQVTQE LRALMDETMK ELKAYKSELE EQLTPVAEET RARLSKELQA AQARLGADME DVRGRLVQYR GEVQAMLGQS TEELRVRLAS HLRKLRKRLL RDADDLQKRL AVYQAGAREG AERGLSAIRE RLGPLVEQGR VRAATVGSLA GQPLQERAQA WGERLRARME EMGSRTRDRL DEVKEQVAEV RAKLEEQAQQ IRLQAEAFQA RLKSWFEPLV EDMQRQWAGL VEKVQAAVGT SAAPVPSDNH |
| For Use With (Application) | Functional Assay |
| Source | E. coli |
| Recombinant | Recombinant |
| Name | Human ApoE4 |
4
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human EGF |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | EGF |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco |
5
Promotions Available
Gibco™ Human TPO (Thrombopoietin) Recombinant Protein, PeproTech®
![]()
Gibco™ Human TPO (Thrombopoietin) Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Thrombopoietin |
| Molecular Weight (g/mol) | 18.6 kDa |
| Gene Symbol | THPO |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | SPAPPACDLR VLSKLLRDSH VLHSRLSQCP EVHPLPTPVL LPAVDFSLGE WKTQMEETKA QDILGAVTLL LEGVMAARGQ LGPTCLSSLL GQLSGQVRLL LGALQSLLGT QLPPQGRTTA HKDPNAIFLS FQHLLRGKVR FLMLVGGSTL CVRRAPPTTA VPSRTSLVLT LNEL |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human TPO (Thrombopoietin) |
| Accession Number | P40225 |
| Regulatory Status | RUO |
| Gene Alias | C-mpl ligand; Megakaryocyte colony-stimulating factor; megakaryocyte growth and development factor; megakaryocyte stimulating factor; Mgdf; MKCSF; ML; MPL ligand; Mpllg; MSA; Myeloproliferative leukemia virus oncogene ligand; prepro-thrombopoietin; TDH2A; THCYT1; THPO; Thrombopoietin; thyroid microsomal antigen; thyroid peroxidase; thyroperoxidase; Tpo; TPX |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of human MO7e cells was found to be ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 7066 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
6
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | M-CSF |
| Molecular Weight (g/mol) | 36.4 kDa |
| Gene Symbol | Csf1 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MKEVSEHCSH MIGNGHLKVL QQLIDSQMET SCQIAFEFVD QEQLDDPVCY LKKAFFLVQD IIDETMRFKD NTPNANATER LQELSNNLNS CFTKDYEEQN KACVRTFHET PLQLLEKIKN FFNETKNLLE KDWNIFTKNC NNSFAKCSSR DVVTKP |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Mouse M-CSF |
| Accession Number | P07141 |
| Regulatory Status | RUO |
| Gene Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of M-NFS-60 cells is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 12977 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
7
8
9
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TNF alpha |
| Molecular Weight (g/mol) | 17.3 kDa |
| Gene Symbol | Tnf |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MLRSSSQNSS DKPVAHVVAN HQVEEQLEWL SQRANALLAN GMDLKDNQLV VPADGLYLVY SQVLFKGQGC PDYVLLTHTV SRFAISYQEK VNLLSAVKSP CPKDTPEGAE LKPWYEPIYL GGVFQLEKGD QLSAEVNLPK YLDFAESGQV YFGVIAL |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Mouse TNF-alpha |
| Accession Number | P06804 |
| Regulatory Status | RUO |
| Gene Alias | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF a; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFa; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1 F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Biological Activity | The ED50 as determined by the cytolysis of murine L929 cells in the presence of actinomycin D is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 21926 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
10
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | NGF |
| Molecular Weight (g/mol) | 27 kDa |
| Gene Symbol | NGF |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | SSSHPIFHRG EFSVCDSVSV WVGDKTTATD IKGKEVMVLG EVNINNSVFK QYFFETKCRD PNPVDSGCRG IDSKHWNSYC TTTHTFVKAL TMDGKQAAWR FIRIDTACVC VLSRKAVRRA |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human beta-NGF |
| Accession Number | P01138 |
| Regulatory Status | RUO |
| Gene Alias | B nerve growth factor; beta ngf; beta-nerve growth factor; BetaNGF; beta-NGF; bNGF; b-NGF; HSAN5; MGC161426; MGC161428; nerve growth factor; nerve growth factor (beta polypeptide); nerve growth factor, beta; nerve growth factor, beta polypeptide; nerve growth factor, beta subunit; NGF; NGF b; NGF β; Ngfb; NGFbeta; NGFβ; β nerve growth factor; β NGF; βNGF |
| Biological Activity | Determined by the dose-dependent stimulation of the proliferation of human TF-1 cells. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 4803 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
11
Promotions Available
Gibco™ Human/Mouse/Rat Activin A Recombinant Protein, PeproTech®
![]()
Gibco™ Human/Mouse/Rat Activin A Recombinant Protein, PeproTech®
Recombinant Protein
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene Symbol | Inhba |
| Sequence | GLECDGKVNI CCKKQFFVSF KDIGWNDWII APSGYHANYC EGECPSHIAG TSGSSLSFHS TVINHYRMRG HSPFANLKSC CVPTKLRPMS MLYYDDGQNI IKKDIQNMIV EECGCS |
| For Use With (Application) | Control,Bioactivity |
| Source | CHO cells |
| Name | Human/Mouse/Rat Activin A |
| Accession Number | P08476, P18331, Q04998 |
| Regulatory Status | RUO |
| Gene Alias | activin A; activin beta-A chain; BMP7; BMP-7; Bone morphogenetic protein 7; EDF; Eptotermin alfa; erythroid differentiation factor; erythroid differentiation protein; follicle-stimulating hormone-releasing protein; FRP; FSH-releasing protein; INHB; Inhba; inhibin B subunit; inhibin beta A chain; inhibin beta A protein; inhibin beta A subunit; inhibin beta-A; inhibin beta-A-subunit; inhibin beta-subunit; inhibin subunit beta A; inhibin, beta A; inhibin, beta A (activin A, activin AB alpha polypeptide); Inhibin, beta-1; OP1; OP-1; Osteogenic protein 1; unnamed protein product |
| Gene ID (Entrez) | 16323, 29200, 3624 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
12
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IGF1 |
| Molecular Weight (g/mol) | 7.6 kDa |
| Gene Symbol | IGF1 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | GPETLCGAEL VDALQFVCGP RGFYFNKPTG YGSSIRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPTKAA |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Mouse IGF-I |
| Accession Number | P05017 |
| Regulatory Status | RUO |
| Gene Alias | C730016P09Rik; class 1 insulin-like growth factor I preproprotein; class 2 insulin-like growth factor I preproprotein; H-IGF-1; IBP1; IGF; IGF1; Igf-1; IGF1A; IGFI; Igf-I; IGFIa; IGF-IA; IGF-IB; insulin growth factor-1; Insulin like growth factor; insulin like growth factor 1; insulin-like growth factor 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor I; insulin-like growth factor I (somatomedin C); insulin-like growth factor IB; mechano growth factor; MGF; M-IGF-1; OTTHUMP00000195084; prepro-IGF-I; prepro-insulin-like growth factor I; R-IGF-1; somatomedin; Somatomedin C; Somatomedin-C |
| Biological Activity | The ED50 was determined a cell proliferation assay using FDC-P1 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
| Gene ID (Entrez) | 16000 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
13
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CCL4 |
| Molecular Weight (g/mol) | 7.6 kDa |
| Gene Symbol | CCL4 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | APMGSDPPTA CCFSYTARKL PHNFVVDYYE TSSLCSQPAV VFQTKRGKQV CADPSESWVQ EYVYDLELN |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human MIP-1 beta (CCL4) |
| Accession Number | P13236 |
| Regulatory Status | RUO |
| Gene Alias | ACT2; ACT-2; AT744.1; CC chemokine ligand 4; C-C motif chemokine 4; C-C motif chemokine ligand 4; Ccl4; chemokine (C-C motif) ligand 4; G-26; G-26 T-lymphocyte-secreted protein; HC21; immune activation gene 2; immune activation gene-2; immune activation protein 2; LAG1; LAG-1; Lymphocyte activation gene 1 protein; macrophage inflammatory protein 1-beta; macrophage inflammatory protein-1 beta; MGC104418; MGC126025; MGC126026; MIP-1 beta; MIP1b; MIP-1 B; Mip1-b; MIP1B1; MIP1beta; MIP-1 BETA; MIP-1-beta; MIP1-beta; MIP-1-beta(1-69); MIP-1-beta(3-69); PAT 744; Protein H400; putative MIP-1 beta protein; RP23-320E6.8; SCY4A; SCYA2; Scya4; secreted protein G-26; SIS-gamma; small inducible cytokine A4; small inducible cytokine A4 (homologous to mouse Mip-1 b); small-inducible cytokine A4; T-cell activation protein 2 |
| Biological Activity | Determined by its ability to chemoattract human blood monocytes using a concentration range of 5.0-20.0 ng/ml |
| Gene ID (Entrez) | 6351 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
14
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | RANKL (RANK Ligand) |
| Molecular Weight (g/mol) | 20 kDa |
| Gene Symbol | TNFSF11 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MEKAMVDGSW LDLAKRSKLE AQPFAHLTIN ATDIPSGSHK VSLSSWYHDR GWAKISNMTF SNGKLIVNQD GFYYLYANIC FRHHETSGDL ATEYLQLMVY VTKTSIKIPS SHTLMKGGST KYWSGNSEFH FYSINVGGFF KLRSGEEISI EVSNPSLLDP DQDATYFGAF KVRDID |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human TRANCE (RANKL) (soluble) |
| Accession Number | O14788 |
| Regulatory Status | RUO |
| Gene Alias | CD254; H-RANK-L; hRANKL2; Ly109l; M-Rank-L; ODF; OPG; OPG ligand; OPGL; OPTB2; Osteoclast differentiation factor; osteoprotegerin ligand; Rankl; rank-l; receptor activator of NF-kappaB ligand; receptor activator of nuclear factor kappa B ligand; receptor activator of nuclear factor kappa-B ligand; RP11-86N24.2; sOdf; srankl; TNF-related activation-induced cytokine; Tnfsf11; TNLG6B; Trance; tumor necrosis factor (ligand) superfamily member 11; tumor necrosis factor (ligand) superfamily, member 11; tumor necrosis factor ligand 6 B; tumor necrosis factor ligand superfamily member 11; Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form; tumor necrosis factor superfamily member 11; tumor necrosis factor-related activation-induced cytokine |
| Biological Activity | Determined by its dose-dependent ability to induce reporter gene in HT-29 NF-kappaB Luc reporter cells. |
| Gene ID (Entrez) | 8600 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |